Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference39 articles.
1. Martin WR, Eades CE, Thompson JA, Huppler RE. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J Pharm Exp Ther. 1976;197:517–32.
2. Su TP. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther. 1982;223:284–90. https://doi.org/10.1007/s00044-020-02574-9
3. Khazan N, Young GA, El-Fakany EE, Hong O, Caliigaro D. Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties. Neuropharmacology. 1984;23:983–7. https://doi.org/10.1016/0028-3908(84)90015-7
4. Bowen WD, de Costa BR, Hellewell SB, Walker JM, Rice KC. [3H]-(+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol Neuropharmacol. 1993;3:117–26.
5. Schmidt HR, Zheng S, Guripinar E, Koehl A, Manglik A, Kruse AC. Crystal structure of the human σ1 receptor. Nature 2016;532:527–30. https://doi.org/10.1038/nature17391. 28